United States Pain Management Therapeutics Market Report 2023: Neurostimulation and Online Pharmacies Surges – Forecasts to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “United States Pain Management Therapeutics Market, Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Pain Management Therapeutics Market in the United States demonstrates robust growth, projected to achieve a market size of US$ 33.71 Billion by 2030. This sector is a critical component of the healthcare industry, aiming to enhance the quality of life for patients experiencing pain.

The market is subdivided into therapeutics such as Pharmaceuticals and Devices, with a significant emphasis on innovative, more tailored approaches to pain management that hold promise for individuals in need. The report highlights a substantial investment in research and development by major pharmaceutical organizations to produce advanced pain management solutions.

Innovations in Pain Management Devices Foster Market Development

• Electrical Stimulators
• Radiofrequency Ablation
• Analgesic Infusion Pumps
• Neurostimulation – identified as the fastest-growing segment, offering a non-pharmacological alternative that addresses the need for safer and personalized pain treatment.

Opioids Maintain Dominance in Drug Class Sector Despite Challenges

Opioids continue to hold the largest share in the United States pain management drug market. Acknowledging the complications related to addiction and side effects, the sector is navigating towards safer alternatives and strict regulatory measures. Non-steroidal Anti-inflammatory Drugs (NSAIDs), Anesthetics, Anticonvulsants, and Non-narcotic Analgesics are also making a considerable impact in the market.

Online Pharmacies Emerge as a Vital Distribution Channel

Owing to the convenience and vast accessibility, online pharmacies are experiencing the highest growth within the US pain management drug industry. They provide a broad array of pain management pharmaceuticals and cater to the demands of the technology-savvy consumer base, significantly contributing to the industry’s expansion.

Different pain types and indications are thoroughly analyzed within the Therapeutics Market, extending across:

• Chronic Pain – occupying the highest market share
• Acute Pain
• Various pain-related conditions such as Arthritic Pain, Cancer Pain, and more

The report underscores the efforts of key market players in the pain management industry, including Eli Lilly and Company, Pfizer Inc., and Johnson & Johnson, who have been pivotal in driving the substantial growth of this market through innovative solutions, partnerships, and educational initiatives.

This comprehensive analysis delves into the dynamics of the US Pain Management Therapeutics Market, offering insights into market segmentation, emerging trends, and growth strategies that are shaping the industry’s future. With an aging population and an increase in chronic pain conditions, the market is set to continue its trajectory of growth and transformation, providing relief and hope to millions of Americans.

For more information about this report visit https://www.researchandmarkets.com/r/9vl6w9

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900